Heart Failure Review Course

October 23-25 Tampa, Florida

The Practical Management of Heart Failure:

From Prevention to Advanced Disease

Heart Failure

Review Course

Designed for cardiologists, internists, nurses, pharmacists and other clinicians with a special interest in heart failure

“Fantastic talks and curriculum”

“Excellent evidence-based discussion and review” “Fantastic! Concise and clinically relevant” “Will recommend to colleagues and staff”

2015 HFSA Comprehensive Review & Update

2

0

1

5

The Practical Management of Heart Failure:

From Prevention to Advanced Disease

2015 HFSA Comprehensive Review & Update

The 2015 Comprehensive Review builds upon HFSA’s successful 2013 Review and 2014 Board Review Course in Advanced Heart Failure and Transplant Cardiology by

incorporating results of new research studies, increasing focus on practical management recommendations, addressing issues encoun-tered in practice, adding case studies, and providing breakout session in areas of special interest.

EduCaTional FoRMaT:

Evidence-based presentations including guideline-based practice recommendations. Breakout sessions and case study sessions focus-ing on practical management issues.

inTEndEd audiEnCE:

Cardiologists, internists, nurses, clinical pharmacists and other health professionals with a special interest in heart failure.

ConTinuing EduCaTion CREdiT:

Physicians: The Heart Failure Society of America is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Heart Fail-ure Society of America designates this live activity for a maximum of 18 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurses: This program has been approved by the American Associa-tion of Critical Care Nurses (AACN) for 18.00 Contact Hours, Synergy CERP Category A, File Number 00019362.

Pharmacist: The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been accredited for up to 18.15 credit hours.

Day 1 Session 1 0046-9999-15-171-L01-P .2CEUs Day 1 Session 2 0046-9999-15-172-L01-P .215CEUs Day 1 Session 3 0046-9999-15-173-L01-P .215CEUs Day 1 Breakout Session 1 0046-9999-15-174-L01-P .075CEUs Day 2 Session 4 0046-9999-15-175-L01-P .15CEUs

Day 2 Session Breakout Session 2 0046-9999-15-176-L01-P .075CEUs Day 2 Session 5 0046-9999-15-177-L01-P .175CEUs

Day 2 Session 6 0046-9999-15-178-L01-P .175CEUs

Day 2 Breakout Session 3-1 0046-9999-15-179-L01-P .075CEUs Day 2 Breakout Session 3-2 0046-9999-15-180-L01-P .075 CEUs Day 3 Session 7 0046-9999-15-181-L01-P .175 CEUs Day 3 Breakout Session 4 0046-9999-15-182-L01-P .075 CEUs Day 3 Session 8 0046-9999-15-183-L01-P .115 CEUs

lEaRning objECTivEs:

Following this meeting, participants will be able to:

1. Describe the epidemiology of heart failure and implement strate-gies for the prevention of heart failure.

2. Describe the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms. 3. Assess and follow the patient with acute or advanced heart failure,

using non-invasive and invasive tests and biomarkers.

4. Implement guideline-based therapy for patients with chronic heart failure, including pharmacologic agents; non-pharmacolog-ic options, such as diet and exercise; and implantable devnon-pharmacolog-ices. 5. Implement appropriate care strategies for patients

undergoing chemotherapy or with pulmonary

hypertension, heart failure with preserved ejection fraction, or cardiorenal syndrome.

6. Manage comorbidities in patients with chronic heart failure, including sleep disordered breathing, anemia, and

depression.

7. Implement strategies for effective disease management of the patient with advanced heart failure, including palliative care and transition to outpatient care.

8. Provide peri-operative management of heart failure patients undergoing cardiac transplantation or implantation of a mechanical circulatory device.

9. Practice effectively in the context of health care reform.

loCaTion:

The 2015 HFSA Heart Failure Review Course will be held at the Sher-aton Tampa East 20 minutes from Tampa International Airport (TPA) and 10 minutes from downtown Tampa. The hotel offers compli-mentary shuttle service to destinations within a 5 mile radius which include the Seminole Hard Rock Casino, Brandon Town Center and Live Nation Amphitheatre.

FaCulTY

Barry H. Greenberg, MD

Distinguished Professor of Medicine Director, Advanced Heart Failure Treatment Program

University of California, San Diego La Jolla, CA

J. Herbert Patterson, PharmD, FCCP

Professor of Pharmacy and Research Professor of Medicine

Executive Vice Chair, Division of

Pharmacotherapy and Experimental Therapeutics University of North Carolina

Eshelman School of Pharmacy, Chapel Hill, NC

Sara Paul DNP, FNP, CHFN

Director, Heart Function Clinic Catawba Valley Cardiology, Hickory, NC

Kirkwood Adams, MD

Associate Professor

Department of Medicine – Cardiology Department of Radiology

University of North Carolina

Univ. of North Carolina at Chapel Hill, Chapel Hill, NC

Larisa Cavallari, PharmD

Associate Professor, Director Center for Pharmacogenomics

University of Florida, College of Pharmacy Univ. of Florida, Gainsville, FL

Leslie T. Cooper, Jr., MD

Professor of Medicine

Chair, Department of Cardiovascular Disease Mayo Clinic, Jacksonville, FL

Mark Drazner, MD

Medical Director of the Heart Failure, LVAD, and Cardiac Transplantation Program

James M. Wooten Chair in Cardiology Professor, Internal Medicine

University of Texas Southwestern Medical Center Dallas, TX

James C. Fang, M.D., F.A.C.C., F.A.H.A.

Professor of Medicine

Chief, Division of Cardiovascular Medicine Executive Director, Cardiovascular Service Line University of Utah, Salt Lake City, UT

Barbara Fletcher, MSN, RN, FAHA, FPCNA, FAAN

Clinical Associate Professor

School of Nursing Brooks College of Health University of North Florida, Jacksonville Jacksonville, FL

Michael G. Fradley, MD

Assistant Professor of Medicine Director, Cardio-Oncology Program

University of South Florida and Moffitt Cancer Center Univ. of South Florida Moffit Cancer Center, Tampa, FL

Marie Galvao, ANP-BC, CHFN

Lead Heart Failure Nurse Practitioner Center for Advanced Cardiac Therapy Montefiore Medical Center, Bronx, N.Y.

Marvin A. Konstam, MD

Professor of Medicine, Tufts University

Chief Physician Executive, Cardiovascular Center Tufts Medical Center, Boston, MA

Alan Miller, MD

Professor, Department of Medicine Division of Cardiology

University of Florida, Jacksonville, FL

Leslie W. Miller, MD, FACC

Director of Heart Failure and Stem Cell Research Heart & Vascular Institute, Clearwater, FL

Gerald V. Naccarelli, MD

Bernard Trabin Chair in Cardiology Professor of Medicine

Chief of the Division of Cardiology

Penn State Hershey Heart and Vascular Institute Penn State Milton Hershey Medical Center, Hershey, PA

Sean P. Pinney, MD

Director, Heart Failure and Transplantation, The Mount Sinai Health System

Director, Advanced Heart Failure and Transplantation Program, The Mount Sinai Hospital, New York, NY

Lisa D. Rathman, MSN, CRNP, CCRN

Lead Nurse Practitioner

Lancaster General Health CHF Clinic Lancaster, PA

Margaret M. Redfield, MD

Professor of Medicine

Mayo Clinic, College of Medicine Director, Mayo Heart Failure Clinic Rochester, MN

Jo E. Rodgers, PharmD, FCCP, BCPS

Clinical Associate Professor

Associate Director, Clinical Fellowship Programs Division of Pharmacotherapy and Experimental Therapeutics

UNC Eshelman School of Pharmacy, Chapel Hill, NC

Bernadette Shields, RN

Nurse Coordinator, CardioOncology Moffitt Cancer Center, Tampa, FL

Teresa Vo, PharmD

Department of Pharmacy Practice and Clinical Research University of South Florida, College of Pharmacy Univ. of South Florida Moffit Cancer Center, Tampa, FL

Payman Zamani, MD

Instructor

Division of Cardiovascular Medicine Perelman School of Medicine

University of Pennsylvania, Philadelphia, PA

As a provider accredited by ACCME, HFSA must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Directors, planning committee members, and speakers are required to disclose all relevant financial relationships. Faculty will also disclose off-label or investigational uses of pharmaceuticals or devices discussed in their presentations.

Disclosure will be published in course materials.

agEnda

THuRsdaY, oCTobER 22

5:00 - 7:00pm opening Reception

7:00 - 8:30pm Hands-on Workshop (non-CME)

Sponsored by Medtronic

FRidaY, oCTobER 23

7:00am Registration/breakfast

7:55am Welcome and introduction

SESSION 1

8:00am Epidemiology and Risk Factor Modification

Alan Miller, MD

8:20am Management of obesity and Hypertension

Alan Miller, MD

8:40am Treating the stage a and b Patient to Prevent

Heart Failure

Barry Greenberg, MD

9:00am update on Heart Failure Pathophysiology

Mark Drazner, MD

9:45am Question and answers

Faculty

10:00am Refreshment break

SESSION 2

10:15am Clinical assessment of Heart Failure

Mark Drazner, MD

10:45am biomarkers in Patients with Heart Failure

Kirkwood Adams, MD

11:15am Echo and other imaging Techniques

Margaret Redfield, MD

11:45am Pulmonary Hypertension

Margaret Redfield, MD

12:15pm Question and answers

Faculty

12:30pm lunch

SESSION 3

1:30pm Medical Therapy of stage C Heart Failure

Marvin Konstam, MD

2:30pm diagnosing and Treating Heart Failure with HFpEF

Margaret Redfield, MD

3:00pm Refreshment break

3:15pm Emerging Therapies in Heart Failure

Barry Greenberg, MD

3:45pm Case Presentation, Question and answer

Case Presenter: Marvin Konstam, MD Panelist: Barry Greenberg, MD Sara Paul, DNP, FNP

Herb Patterson, PharmD

Margaret Redfield, MD

4:15pm BREAKOUT SESSIONS 1

A. outpatient Monitoring

Alan Miller, MD Lisa Rathman, MSN

B. basic Pharmacogenomics for the

Heart Failure Clinician

Kirkwood Adams, MD Larisa Cavallari, PharmD Herb Patterson, PharmD

C. Chemotherapy and Cardio-oncology

Michael Fradley, MD Bernadette Shields, RN Teresa Vo, PharmD

5:00pm adjourn

saTuRdaY, oCTobER 24

7:30am light breakfast

SESSION 4

8:00am acute Heart Failure

James Fang, MD

8:30am Transitions of Care and Preventing 30 day

Readmissions

Sara Paul, DNP, FNP

9:00am Preventing sudden Cardiac death

Gerald Naccarelli, MD

9:30am Question and answers

Faculty

9:45am BREAKOUT SESSIONS 2

A. How to Manage sleep disordered breathing

in Heart Failure

James Fang, MD Lisa Rathman, MSN

B. nuts and bolts of Transition of Care

Kirkwood Adams, MD

Sara Paul, DNP, FNP

Jo Ellen Rodgers, PharmD

C. Evaluation of the newly diagnosed Patient

Leslie Cooper, MD Marie Galvao, ANP-BC Herb Patterson, PharmD

10:30am Refreshment break

SESSION 5

10:45am inflammatory and infiltrative Cardiomyopathies

Leslie Cooper, MD

11:15am atrial Fibrillation

Gerald Naccarelli, MD

11:45am update on iCds and CRT

Gerald Naccarelli, MD

12:15pm Question and answers

Faculty

12:30pm lunch

SESSION 6

1:30pm Management of secondary Mitral Regurgitation

James Fang, MD

2:00pm Challenging Co-Morbidities: anemia,

depression and sleep disordered breathing

Lisa Rathman, MSN

2:30pm Right Heart Failure

Payman Zamani, MD

3:00pm Question and answers

Faculty

3:15pm Refreshment break

3:30pm BREAKOUT SESSIONS 3

A. How to Manage new anticoagulants

Jo Ellen Rodgers, PharmD Payman Zamani, MD

B. How to Manage Cardiorenal syndrome

Marie Galvao, ANP-BC Marvin Konstam, MD Herb Patterson, PharmD

C. selection of Patients for Percutaneous Treatment

of valvular disease

James Fang, MD

4:20pm BREAKOUT SESSIONS 3 (Repeats)

5:05pm adjourn

sundaY, oCTobER 25

7:30am light breakfast

SESSION 7

8:00am stage d Heart Failure: Recognition and Treatment options

Barry Greenberg, MD

8:30am acute and Chronic MCs

Sean Pinney, MD

9:00am Cardiac Transplantation: Patient selection and

Pre/Post-transplant Management

Sean Pinney, MD

9:30am Question and answers

Faculty

9:45am Refreshment break 10:00am BREAKOUT SESSIONS 4

A. Exercise and Cardiac Rehabilitation

Barbara Fletcher, MSN, RN Payman Zamani, MD

B. Principles and Practice of immunosuppression

for Transplant

Leslie Miller, MD Jo Ellen Rodgers, PharmD

SESSION 8

10:50am Palliative Care and Hospice

Marie Galvao, ANP-BC

11:20am Complex Case studies

Case Presenter: Sean Pinney, MD Panelist: Leslie Cooper, MD Marie Galvao, ANP-BC Jo Ellen Rodgers, PharmD

11:50am overview & Highlights

Barry Greenberg, MD

12:00pm adjourn

REgisTRaTion & aCCoMModaTions

REgisTRaTion

Register online: www.hfsa.org

Registration Fee HFSA Members: Advance by 8/30/15 After 8/30/15

MD, DO  $750  $900

Gold Package *  $1,260  $1,410

Nurse, Nurse Practitioner, Pharmacist, Other Health Professional  $550  $700

Gold Package *  $860  $1,010

Registration Fee Non-members:

MD, DO  $950  $1,100

Gold Package *  $1,560  $1,710

Nurse, Nurse Practitioner, Pharmacist, Other Health Professional  $750  $900

Gold Package *  $1,160  $1,310

* includes attendance at the live meeting and access to HFSA Comprehensive Review on Demand, so you can watch sessions anytime, anywhere. On Demand includes all session from the 2015 Course plus sessions in three special focus areas from the 2014 Board Review: Cardiomyopathies, Pathophysiology, Non-Transplant Surgery and Mechanical Circulatory Support.

Refunds: If notice of cancellation is received in writing prior to August 15, 2015, registration fee will be refunded less a $150 administrative charge. Registration cannot be transferred. No refunds will be issued after August 15, 2015.

sHERaTon TaMPa EasT Discounted Group Rate: $99.00 per night!

10221 Princess Palm Avenue

Tampa, FL 33610 Phone: 813-623-6363

Website: https://www.starwoodmeeting.com/Book/HFSA2015

Hotel: The 2015 HFSA Heart Failure Review Course will be held at the Sheraton Tampa East 20 minutes from Tampa International Airport (TPA) and 10 minutes from downtown Tampa. The hotel offers complimentary shuttle service to destinations within a 5 mile radius which includes the Seminole Hard Rock Casino, Brandon Town Center and Live Nation Amphitheater. You are urged to make your reservations early. A limited block of guest rooms had been reserved for attendees with a special course rate of $99 single occupancy per night at the Sheraton Tampa East. The cut off date for this group rate is September 11, 2015. Group rates will be honored 3 days prior and 3 days following the course dates, based upon space availability.

Travel: For assistance on travel arrangements please contact Nadine Taylor with GMI at nadine@gmimeetings.com or 360-254-2427. A small transaction fee will apply. If you are interested in group transportation from/to Tampa International Airport please contact HFSA at info@hfsa.org or 301-312-8635. Or consider using a transportation company like Uber for more economical transportation options. Complimentary wifi will be available in all guest room and meeting rooms.

Tampa, F

lorida

The Prac

tic

al M

anagement of H

ear

t F

ailur

e:

From P

rev

en

tion t

o A

dv

anc

ed D

isease

t F

ailur

e

vie

w C

ourse

0

1

5

Sponsor ed b y the H ear t F ailur e S ociet y of Americ a w w w.hf sa.or g

Hear

t F

ailur

e s

ociet

y of

americ

a

6707 D

emocr

ac

y Blv

d., Suit

e 925

Bethesda, MD 20817

Please P

ost

2015 HFSA

Comprehensive Review & Update

Non-Profit Org. U.S. Postage

PAID

Suburban MD Permit No. 800

eu non profit indicia.indd 1